FY FINANCIAL (08452) released its mid-term results, reporting a loss attributable to shareholders of 8.665 million yuan, an increase of 662% year-on-year.
Fuyin Finance Co., Ltd. (08452) announced its interim results for the six months ended June 30, 2026, reporting revenue of 5.418 million yuan, a decrease of 88.38% year-on-year; the loss attributable to shareholders was 8.665 million yuan, an increase of 662% year-on-year; the loss per share was 2.41 cents.
FY FINANCIAL (08452) announced its interim results for the six months ended June 30, 2026, with the group achieving revenue of HKD 5.418 million, a decrease of 88.38% year-on-year; the loss attributable to equity holders of the company was HKD 8.665 million, an increase of 662% year-on-year; loss per share was 2.41 cents.
Related Articles
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
RECOMMEND
